Dark Forest Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Dark Forest Capital Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$744K	Buy	+78,103	New	+$607K	0.07%	453
2025 Q2	–	Sell	-32,464	Closed	-$243K	–	1189
2025 Q1	$243K	Buy	32,464 +2,771	+9%	+$22.4K	0.01%	1113
2024 Q4	$223K	Sell	29,693 -19,683	-40%	-$149K	0.03%	783
2024 Q3	$375K	Buy	+49,376	New	+$375K	0.05%	510
2022 Q4	–	Sell	-6,732	Closed	-$85K	–	1150
2022 Q3	$85K	Buy	6,732 +6,694	+17,616%	+$86.1K	0.02%	485
2022 Q2	$0	Buy	+38	New	+$392	﹤0.01%	906
2021 Q3	–	Sell	-1,919	Closed	-$30K	–	1267
2021 Q2	$30K	Buy	+1,919	New	+$26.1K	0.01%	516

Other funds holding BCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return